ALHC logo

Alignment Healthcare, Inc. Stock Price

NasdaqGS:ALHC Community·US$4.8b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 17 Fair Values set on narratives written by author

ALHC Share Price Performance

US$23.26
9.26 (66.14%)
US$24.92
Fair Value
US$23.26
9.26 (66.14%)
6.7% undervalued intrinsic discount
US$24.92
Fair Value
Price US$23.26
AnalystConsensusTarget US$24.92
AnalystLowTarget US$18.15
AnalystHighTarget US$30.00

ALHC Community Narratives

·
Fair Value US$24.92 6.7% undervalued intrinsic discount

ALHC: Margin Recovery Will Drive Medicare Advantage Market Share Gains

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
·
Fair Value US$18.15 28.1% overvalued intrinsic discount

Rising CMS Pressures And Margin Risks Will Drag Performance

0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
·
Fair Value US$30 22.5% undervalued intrinsic discount

Digital Health And Aging Population Will Advance Coordinated Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$18.15
28.1% overvalued intrinsic discount
Revenue
24.5% p.a.
Profit Margin
1.68%
Future PE
38.03x
Price in 2029
US$22.29
US$24.92
6.7% undervalued intrinsic discount
Revenue
27.01% p.a.
Profit Margin
2.26%
Future PE
36.5x
Price in 2029
US$30.6

Trending Discussion

Updated Narratives

ALHC logo

ALHC: Reset Multiples And Execution Risks Will Shape Balanced Return Potential

Fair Value: US$18.15 28.1% overvalued intrinsic discount
0 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative
ALHC logo

ALHC: Managed Care Positioning And Membership Trends Will Support Margin Recovery

Fair Value: US$24.92 6.7% undervalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ALHC logo

ALHC: Higher Revenue And Margin Assumptions Will Support Earnings Visibility

Fair Value: US$30 22.5% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Exceptional growth potential and undervalued.

1 Risk
4 Rewards

Alignment Healthcare, Inc. Key Details

US$4.3b

Revenue

US$3.7b

Cost of Revenue

US$527.0m

Gross Profit

US$507.2m

Other Expenses

US$19.8m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.096
12.38%
0.47%
156.4%
View Full Analysis

About ALHC

Founded
2013
Employees
1849
CEO
John Kao
WebsiteView website
www.alignmenthealth.com

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

Recent ALHC News & Updates

Seeking Alpha Jun 29

Alignment Healthcare: A 33% Grower Worth Owning At 48x Forward Earnings, Just Not Yet

Summary Alignment Healthcare hit a profitability inflection in Q1 2026, growing revenue 33% and expanding margins while holding its medical cost ratio steady near 88%. Management raised full-year 2026 guidance across membership, revenue, gross profit, and EBITDA, and analyst estimate revisions have been uniformly positive over the past 90 days. Despite the strong operations, ALHC trades at roughly 48.8 times forward earnings and 28.6 times forward EBITDA, a clear premium to Medicare Advantage peers, leaving little margin of safety. I rate ALHC a Hold. Fair value sits near $20–22 against a current price around $23, and the stock's history of sharp drawdowns suggests a better entry will come. Read the full article on Seeking Alpha
Analysis Article Jun 20

Alignment Healthcare (ALHC) Stock Could Be 12.3% Undervalued After Earnings Beat

Alignment Healthcare (ALHC) has drawn fresh attention after reporting quarterly earnings ahead of expectations and outlining a leadership reshuffle, with CEO John Kao adding Chairman responsibilities as Joseph Konowiecki becomes Vice Chairman and Executive Vice President of Corporate Affairs. See our latest analysis for Alignment Healthcare. Alignment Healthcare's recent earnings beat and leadership changes come on the back of strong momentum, with a 33.54% 1 month share price return and a...

Recent updates

No updates